CAM
EBS icon

Costello Asset Management’s Emergent Biosolutions EBS Stock Holding History

Costello Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Hold
400
– – ﹤0.01% 626
2026
Q1 		$3.32K Hold
400
– – ﹤0.01% 595
2025
Q4 		$4.94K Hold
400
– – ﹤0.01% 562
2025
Q3 		$3.53K Hold
400
– – ﹤0.01% 581
2025
Q2 		$2.55K Hold
400
– – ﹤0.01% 618
2025
Q1 		$1.94K Buy
+400
New +$3.31K ﹤0.01% 617

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Costello Asset Management's EBS Position: Q2 2026 in Review

Costello Asset Management held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 400 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Costello Asset Management first reported a position in EBS in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.94K in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Costello Asset Management held 400 shares of Emergent Biosolutions worth $3.35K as of Q2 2026.
  • Costello Asset Management left its Emergent Biosolutions share count unchanged in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Costello Asset Management's portfolio in Q2 2026, its #626 holding.
  • Costello Asset Management first reported a position in Emergent Biosolutions in Q1 2025 and has held it in 6 quarters since.
  • Costello Asset Management's Emergent Biosolutions position peaked at $4.94K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.